好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Extended Interval Dosing of Natalizumab: A Single Center Experience
MS and Related Diseases
(-)
200
Authors/Disclosures
Yazan Alderazi, MD, MB BCh BAO (HCA- Houston Healthcare) No disclosure on file
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Roberto Bomprezzi, MD, FAAN (University of Massachusetts, Dept. of Neurology) Dr. Bomprezzi has nothing to disclose.
Alberto Maud, MD (Paul L. Foster School of Medicine Texas Tech UHSC El Paso, Texas) Dr. Maud has nothing to disclose.